PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsStem cells partially reverse disability in small MS trial

BioNews

Stem cells partially reverse disability in small MS trial

Published 26 January 2015 posted in News and appears in BioNews 787

Author

Dr Tamara Hirsch

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).

An early clinical trial investigating a new form of stem cell therapy for multiple sclerosis has demonstrated neurological improvement and enhanced quality of life for patients...

An early clinical trial investigating a new form of stem cell therapy for multiple sclerosis (MS) has demonstrated neurological improvement
and enhanced quality of life for patients. The research, published in JAMA, suggested
reversal of some of the debilitating effects of MS.

Researchers at the Northwestern University Feinberg School
of Medicine, Chicago, USA, assessed a small group of 145 patients with MS. The novel approach used low-dose chemotherapy combined with an
infusion of the patients' own stem cells in order to 'reset' their immune
systems.

The study employed a standardised measure of disability associated
with neurological impairment, the Expanded Disability Status Scale (EDSS), which
showed a significant improvement in 50 percent of patients tested at two years and 64 percent of patients tested at four years.

'This is the first report of significant and sustained
improvement in the EDSS score following any treatment for MS,' say the authors.

MS disease progression and severity were also assessed according
to the total volume of brain lesions, using magnetic resonance imaging, and a
significant decrease in overall lesion volume was evident following stem cell
therapy.

MS is an immune-­mediated disorder of the central nervous
system in which the immune system mistakenly attacks the protective coating
surrounding fibers in the brain and spine known as the myelin sheath. Following
diagnosis, approximately 50 percent of patients with MS are unable to continue
employment ten years after diagnosis or to walk after 25 years.

Despite widespread research efforts, there is currently no commercialised treatment for MS that is effective in
reversing neurological impairment or improving patients' quality of life.
Available drugs are only able to slow progression of the disease.

The authors note that the current study is limited
by the lack of a control group and because effects were only seen among patients with the relapsing-remitting form of the disease and not in those with secondary-progressive MS, which is more severe. Nor were effects seen in those who had been affected by the disease for more than ten years.

Nonetheless the findings should provide a strong basis for initiating a
randomised study within an appropriate patient population, the authors conclude.

Related Articles

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
26 February 2018 • 2 minutes read

Human stem cells help paraplegic rats walk again

by Ewa Zotow

Paraplegic rats were able to walk after being treated with human stem cells. This is the first time lower body movement has been restored after an animal's spinal cord has been completely severed...

PET BioNews
News
25 April 2017 • 3 minutes read

Stem cell treatment halts multiple sclerosis for five years

by Jamie Rickman

A study has demonstrated that a new, one-off stem cell treatment for multiple sclerosis can 'freeze' progression of the disease for five years in some patients...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
22 January 2016 • 3 minutes read

Adult stem cells reverse multiple sclerosis in UK trial

by Dr Lanay Griessner

A stem cell treatment routinely used for bone and blood cancers is showing promise at reversing the effects of multiple sclerosis...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
28 August 2015 • 2 minutes read

Genetic findings confirm vitamin D—MS link

by Lubna Ahmed

A recent study by researchers in Canada has found that people who are genetically susceptible to low vitamin-D levels are at a higher risk of multiple sclerosis...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
8 May 2015 • 3 minutes read

New type of stem cell may help grow organs

by Dr Tamara Hirsch

Scientists have identified a new type of stem cell that shows distinct advantages over those discovered to date, and which could potentially be used to grow human organs in animals such as pigs or cows...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
6 June 2014 • 2 minutes read

Human embryonic stem cells perform well in multiple sclerosis mouse study

by Isobel Steer

Human embryonic stem cells have been shown to be more effective in treating multiple sclerosis (MS) in mice than bone marrow stem cells, a study has found...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
16 May 2014 • 2 minutes read

Human stem cells reverse multiple sclerosis in mice

by Alice Plein

Mice with a viral form of multiple sclerosis are able to walk again after receiving a transplant of human stem cells, scientists report...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
7 October 2013 • 2 minutes read

Global study finds 48 new multiple sclerosis risk genes

by Julianna Photopoulos

A group of international researchers has identified 48 new genetic variants that influence the risk of developing multiple sclerosis. This brings the number of genetic 'risk factors' linked to the disease to 110...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
9 June 2009 • 2 minutes read

Stem cell hope for multiple sclerosis

by Dr Rebecca Robey

A promising new stem cell therapy has reversed the effects of multiple sclerosis (MS) for the first time. In a small clinical trial published in the journal Lancet Neurology, researchers from the Northwestern Freinberg School of Medicine, Chicago, US, treated MS sufferers with their own stem cells...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Complications for IVF babies declining, says Scandinavian study

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856